We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hospira Warned Over GMP Violations at India Plant
Hospira Warned Over GMP Violations at India Plant
July 1, 2013
Injectable drug giant Hospira has landed in hot water with the FDA again, this time receiving a warning letter for GMP violations at its India plant.